Search Results 1351-1360 of 7363 for Synchrotron
Mayo Clinic researchers say that hypothesis-driven AI can offer an innovative way to use massive datasets to help discover the complex causes of diseases.
Latest stories · Mayo Clinic M.D., Ph. · Tumor cell PD-L1 may mediate sensitivity to chemotherapy in colorectal cancer treatment featured image · Mayo Clinic study ...
Research · Revealing the hidden tips for success as an academic researcher featured image · Mayo Clinic researchers publish key findings about cell proteins to ...
About this study. This randomized, double-blind, placebo-controlled, multicenter, confirmatory study will evaluate the efficacy and safety of Cook MyoSite ...
As a pulmonologist and genomic scientist, Victor Ortega, M.D., Ph.D., is leading a charge to breathe new life into precision medicine advancements. His mission ...
The purpose of this study is to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as adjunctive treatment in primary generalized ...
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
Mayo Clinic experimental dual-drug nanotherapy crosses the blood-brain barrier and improved survival · Robotic-assisted bronchoscopy study of more than 2,000 ...
Marla Broadfoot, Ph.D. March 26, 2026. Immunotherapy boosts chemotherapy in combating stage 3 colon cancer featured image. Cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!